Cherubism, a pediatric disease, is a self limiting non-neoplastic autosomal dominant fibro-osseous disorder of jaws. It is a self limiting disease and rarely apparent before the age of two years. It occurs in children and predominantly in boys. It is characterized by clinical bilateral swelling of cheeks due to bony enlargement of jaws that give the patient a typical 'cherubic' look. Regression occurs during puberty when the disease stabilizes after the growth period leaving some facial deformity and malocclusion. Cherubism may occur in solitary cases or in many members of the family, often in multiple generations. Radiographically, lesion appears as bilateral multilocular radiolucent areas. Since it was first described by Jones in 1933, many cases have been documented. Here a case of 8 years old cherubic child, with his clinical appearance as well as radiological evaluation and discussion about clinical outcome are presented. The patient was diagnosed but not treated.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4086575 | PMC |
| http://dx.doi.org/10.5005/jp-journals-10005-1019 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Successful treatment of adult cherubism with a 60 mg denosumab 6-monthly regimen.
JBMR Plus
February 2025
Department of Diabetes and Endocrinology, Royal Melbourne Hospital, Melbourne, VIC 3050, Australia.
Cherubism is a rare autosomal dominant skeletal dysplasia, affecting the maxilla and/or mandible. The condition typically has childhood onset, followed by progression until puberty, with subsequent regression. Cherubism lesions share histological features with giant cell tumor of bone, where high-dose monthly denosumab is an effective medical treatment.
View Article and Find Full Text PDFTransconjunctival Orbital Decompression in Cherubism.
Ophthalmic Plast Reconstr Surg
December 2024
Department of Ophthalmology, School of Medicine of Ribeirão Preto, University of São Paulo.
Cherubism is a rare fibro-osseous disease characterized by the progressive expansion of the mandible and maxilla during childhood. Orbital involvement occurs in a subset of patients and is clinically manifested as upward displacement of the affected eye. The bony changes tend to spontaneously diminish or even regress after puberty.
View Article and Find Full Text PDFNot All Chubby Cheeks Are Cute: A Case of Cherubism.
Cureus
July 2024
Department of Radiology, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth (Deemed to be University), Pune, IND.
The growth of the jaw occurs painlessly in cherubism, a rare genetic disorder where normal bone is replaced by fibrous tissue and undeveloped bone. Usually running in families, this non-cancerous genetic condition naturally reaches a limit and stops growing. The main characteristic is the aberrant growth of osseous and fibrous tissue in the maxilla and mandible, which is frequently seen in children.
View Article and Find Full Text PDFGenetic Variants in the Gene Are Associated with Ramon Syndrome and Hereditary Gingival Fibromatosis.
Int J Mol Sci
August 2024
Center of Excellence in Medical Genetics Research, Faculty of Dentistry, Chiang Mai University, Chiang Mai 50200, Thailand.
Ramon syndrome (MIM 266270) is an extremely rare genetic syndrome, characterized by gingival fibromatosis, cherubism-like lesions, epilepsy, intellectual disability, hypertrichosis, short stature, juvenile rheumatoid arthritis, and ocular abnormalities. Hereditary or non-syndromic gingival fibromatosis (HGF) is also rare and considered to represent a heterogeneous group of disorders characterized by benign, slowly progressive, non-inflammatory gingival overgrowth. To date, two genes, and , have been linked to Ramon syndrome.
View Article and Find Full Text PDFPLCG2 variants in cherubism.
J Allergy Clin Immunol
December 2024
Department of Pediatrics, Division of Allergy, Immunology, and Rheumatology, Columbia University, New York, NY. Electronic address:
Background: Cherubism is most commonly caused by rare heterozygous gain-of-function (GOF) missense variants in SH3BP2, which appear to signal through phospholipase C gamma 2 (PLCG2) to cause excessive osteoclast activity leading to expansile lesions in facial bones in childhood. GOF variants in PLCG2 lead to autoinflammatory PLCG2-associated antibody deficiency and immune dysregulation (autoinflammatory PLAID, or PLAID-GOF), characterized by variably penetrant autoinflammatory, autoimmune, infectious, and atopic manifestations. Cherubism has not been reported in PLAID to date.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!